Franklin Resources’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-870
Closed -$13.1K 2395
2022
Q4
$13.1K Hold
870
﹤0.01% 2295
2022
Q3
$20K Buy
870
+26
+3% +$771 ﹤0.01% 2258
2022
Q2
$23K Sell
844
-371
-31% -$14.4K ﹤0.01% 2311
2022
Q1
$54K Buy
1,215
+43
+4% +$1.95K ﹤0.01% 2364
2021
Q4
$80K Hold
1,172
﹤0.01% 2367
2021
Q3
$221K Buy
+1,172
New +$228K ﹤0.01% 2199
2018
Q2
Sell
-122
Closed -$290K 1538
2018
Q1
$290K Sell
122
-95
-44% -$285K ﹤0.01% 1423
2017
Q4
$890K Hold
217
﹤0.01% 1327
2017
Q3
$903K Hold
217
﹤0.01% 1302
2017
Q2
$992K Hold
217
﹤0.01% 1304
2017
Q1
$1.19M Hold
217
﹤0.01% 1306
2016
Q4
$973K Hold
217
﹤0.01% 1307
2016
Q3
$4.55M Hold
217
﹤0.01% 1124
2016
Q2
$3.31M Hold
217
﹤0.01% 1170
2016
Q1
$6.03M Hold
217
﹤0.01% 1065
2015
Q4
$6.21M Hold
217
﹤0.01% 1093
2015
Q3
$5.4M Hold
217
﹤0.01% 1130
2015
Q2
$18.4M Buy
217
+71
+49% +$6.5M 0.01% 903
2015
Q1
$14.8M Buy
146
+26
+22% +$3.46M 0.01% 959
2014
Q4
$15.5M Buy
120
+16
+15% +$1.17M 0.01% 955
2014
Q3
$5.07M Hold
104
﹤0.01% 1181
2014
Q2
$2.8M Hold
104
﹤0.01% 1265
2014
Q1
$2.73M Hold
104
﹤0.01% 1242
2013
Q4
$2.79M Hold
104
﹤0.01% 1221
2013
Q3
$3.03M Buy
+104
New +$3.69M ﹤0.01% 1185

Other funds holding TPST

Franklin Resources's TPST Position: Q1 2023 in Review

Franklin Resources sold out of Tempest Therapeutics (TPST) in Q1 2023, closing a stake of 870 shares — an estimated $13.1K sold.

Franklin Resources first reported a position in TPST in Q3 2013 and held it in 25 quarters. The position peaked at $18.4M in Q2 2015. 17 funds tracked by Wall St. Rank hold TPST as of Q1 2023.

  • Franklin Resources reported no remaining Tempest Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Franklin Resources sold 870 Tempest Therapeutics shares in Q1 2023, an estimated $13.1K.
  • Franklin Resources first reported a position in Tempest Therapeutics in Q3 2013 and held it in 25 quarters.
  • Franklin Resources's Tempest Therapeutics position peaked at $18.4M in Q2 2015.
  • 17 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2023.

Based on Franklin Resources's 13F filing for Q1 2023, filed 12 May 2023.